Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety, Tolerability, and Efficacy Study of LY2590443 in the Treatment of Acute Migraine Headache

NCT00804973 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00804973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00804973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety, Tolerability, and Efficacy Study of LY2590443 in the Treatment of Acute Migraine Headache
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2008
Completion date
May 31, 2009
Enrollment
120 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache